For the first time all five EATRIS product platforms met together, for plenary discussions covering EATRIS the strategy and goals, ongoing platform activities in platform meetings, and to assess the current state of the art in four emerging technology areas of relevance to translational research. ... read more.
Translational medicine is the transformation of laboratory research outcomes into new ways to diagnose and treat patients to improve the health of millions of people worldwide. It takes promising biomedical innovations 'from bench to bedside' and bridges clinical needs from bedside to bench.
EATRIS provides a new development pathway, open to researchers and companies in need of support for advancing biomedical innovations. EATRIS comprises over 70 leading academic institutions across Europe, each renowned for its individual and high-end research facilities.
This infrastructure provides the following advantages:
- Single point of access to the right expertise and facilities
- Expedites the development process
- Access to large and diverse clinical patient cohorts
I couldn’t believe my ears. Are there still scientists who think they know it all and they know it best? I attended the road show of the KWF, the Dutch Cancer Society. ... read more
The EPSRC Centre for Innovative Manufacturing in Regenerative Medicine this past month, organized a two-day workshop at Madingley Hall, Cambridge in which EATRIS was represented ... read more.
It’s time to validate new statistical approaches for clinical trials if we want to maintain the evidence-based medicine as cornerstone of our drug safety and efficacy evaluation ... read more.
We are happy to share the good news that Norway has joined EATRIS as a member ... read more.
EATRIS ERIC and Reumafonds have initiated a long-term collaboration to advance translational research in rheumatological disorders. ... read more.
EATRIS was honored to Co-organize its second international 2-day workshop with the Ri.MED foundation on ATMP development last month in Palermo, Sicily following the success of the first such course held at the Istituto Superiore di Sanità (ISS) in Rome in September. ... read more.
Following the kick-off meeting in November of the CORBEL project (COordinated Research Infrastructures Building Enduring Life-science Services), the contours of the work package “Accelerating Innovation”, with EATRIS in the lead, are starting to take shape. ... read more.
In collaboration with the European Commission, EATRIS ERIC will be co-organising the 4th ERIC Network meeting, that will take place in Amsterdam on March 8 and 9, 2016. ... read more.
The organisation of the Product Platform Combined Meeting to be held in Barcelona in January 28 – 29th is progressing nicely. ... read more.
EATRIS facilitated a new partnership between IMAXIO, which is an integrated biotech company focused on vaccines (www.imaxio.com) and the Infectious Disease group of the Institute of Biomedicine of Seville (IBiS), Spain (www.ibis-sevilla.es). ... read more.
E-Rare - the ERA-net for research programmes on rare diseases - has opened a joint call to promote clinical and pre-clinical proof of concept studies for the potential application of medicinal products that are either already marketed or having achieved a significant stage in the development process in rare indications. ... read more.
EATRIS welcomes one of the top 10 biomedical institutes in Spain, INCLIVA Health Research. INCLIVA is the institution managing the research for Health of the University of Valencia (School of Medicine), the IVI University Institute and the University Clinic Hospital. ... read more.
ERIC Network meeting
Utrecht, The Netherlands
11th European Molecular Imaging Meeting – EMIM 2016
Biobanking National Infrastructures Meeting